Obesity Management: While the primary indication remains type 2 diabetes treatment, Mounjaro has gained substantial attention for its weight loss effects
HR = 0.90 (125)], even in those patients with previous heart failure (132134), suggesting that the increased risk with saxagliptin is not mechanistically related to the inhibition of DPP-4 per se , but the cause is still unexplained
However, access and insurance coverage may be more challenging, and lower doses are typically used
3, 4, 5 However, it is the paracellular pathway, regulated by the tight junction (TJ), that is responsible for the greatest degree of apical cellcell adhesion, 6, 7 and which has received the most attention for its role in regulating mucosal permeability under normal and pathological conditions